Health Care

Why Is Penny Stock Clearmind Gaining Today?

Schwab US Dividend Equity ETF Reverses In December: What's Going On?

EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease

Schwab US Dividend Equity ETF Reverses In December: What's Going On?

EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease

The World's Most Valuable Neurotech Company Builds an Alarm System for Your Brain

Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More

The World's Most Valuable Neurotech Company Builds an Alarm System for Your Brain

Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More

Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug

Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data

Health Care Recent News

What's Going On With Amgen Stock On Friday?

Novo Nordisk's CagriSema shows 22.7% weight loss in Phase 3 trials, while tolerability concerns grow. MariTide offers competitive weight loss with less frequent dosing.

Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252%

Billionaire Stanley Druckenmiller's latest large wager on biotech company Natera Inc has paid off, with his stake now exceeding $575 million.

Rhythm Pharmaceuticals' Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential

Rhythm Pharmaceuticals targets rare obesity disorders with its drug Imcivree, showing strong growth in sales and potential for significant market expansion

Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries

Boston Scientific updates Polarx catheter guidelines due to atrio-esophageal fistula risks, highlighting safer usage practices after FDA approval.

Novo Nordisk Stock Plummets: Bearish Signals Dominate After Drug Trial Miss

Novo Nordisk's stock is spiraling downwards, with technical analysis revealing a concerning picture of bearish momentum. Short-term opportunities may arise, but the broader downtrend remains strong.

EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss

Novo Nordisk's stock plunges 20% after underwhelming weight-loss trial results for its obesity drug. Analysts say market overreacted.

Pyxis Oncology's Deprioritizes Second Pipeline Asset, Analyst Applauds Move

Pyxis Oncology prioritizes PYX-201 with promising Phase 1 results in solid tumors, while deprioritizing PYX-106 due to resource allocation and challenges.

Nebraska Attorney General Sues UnitedHealth Over Massive Data Breach That Disrupted Healthcare

Nebraska Attorney General sues UnitedHealth Group and affiliates over a data breach impacting 575,000 residents, alleging law violations and mishandled response.

Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday?

Galectin Therapeutics' NAVIGATE trial shows belapectin reduces varices in MASH cirrhosis, but falls short of statistical targets; full data due in early 2025.

Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday?

Aadi Bioscience secures ADC portfolio license, involving $44 million upfront and $805 million in milestones plus royalties.

Why Is Bioengineered Human Tissue-Focused Humacyte Stock Surging On Friday?

Humacyte's Symvess earns FDA approval as a first-in-class bioengineered vascular solution for urgent arterial injury repair in trauma cases.

FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood

Ionis' Tryngolza receives FDA approval for familial chylomicronemia syndrome, showing significant triglyceride reduction and fewer pancreatitis events.

Novo Nordisk's Hybrid Weight Loss Drug Falls Short On Expectations, Stock Plunges

Novo Nordisk's REDEFINE 1 trial shows CagriSema delivers significant weight loss and a favorable safety profile in obesity treatment.